US · Healthcare · Medical Devices
EPS came in at -0.28 against a street estimate of -0.22 — a miss of 27.3%.
Analysts rate Neuroone Medical Technologies Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.27.
| Fund | Stake |
|---|---|
| Bleichroeder LP | 7.32% |
| Bard Associates Inc | 3.35% |
| Vanguard Capital Management, LLC | 2.56% |
| Renaissance Technologies Corp | 1.20% |
| Geode Capital Management, LLC | 1.13% |
| Sio Capital Management, LLC | 0.91% |
| Vanguard Fiduciary Trust Co | 0.53% |
| Essex Investment Management Company, LLC | 0.48% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neuroone Medical Technologies Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.